Australia markets open in 8 hours 53 minutes

Tonix Pharmaceuticals Holding Corp (TPM.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
0.38200.0000 (0.00%)
As of 08:01AM CET. Market open.
Full screen
Previous close0.3820
Open0.3820
Bid0.3660 x N/A
Ask0.3960 x N/A
Day's range0.3820 - 0.3820
52-week range0.3820 - 13.6768
Volume5,300
Avg. volume291
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Tonix Pharmaceuticals Announced Data from its Fully Human anti-SARS-CoV-2 Monoclonal Antibody Platform in an Oral Presentation at the World Antiviral Congress

    Research Being Conducted in Collaboration with Scientists at Columbia University SARS-CoV-2 Variants have Evaded Antibody Therapeutics Previously Granted FDA Emergency Use Authorization, but which are No Longer Recommended for Use by the NIH COVID-19 Guidelines Panel Immunocompromised Individuals, Including Organ Transplant Recipients, are at Increased Risk of Severe COVID-19 and Poor Outcomes Therapeutic Antibody Platform Leverages Tonix’s Expanding Internal Development and Manufacturing Capabi

  • GlobeNewswire

    Tonix Pharmaceuticals to Participate in the A.G.P. Biotech Conference

    CHATHAM, N.J., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, announced today that management will participate virtually in the A.G.P. Biotech Conference and host investor meetings. The conference is being held Wednesday, November 30, 2022 – Thursday, December 1, 2022. Investors interested in arranging a meeting with the Company’s management during the conference should contact the conference coordinator or Ian Fr

  • GlobeNewswire

    Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine and Immunotherapy Congress

    CHATHAM, N.J., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, will deliver an oral presentation at the World Vaccine and Immunotherapy Congress 2022, which will be held in San Diego, Calif., November 28 - December 1, 2022. A copy of the Company’s presentation will be available under the Scientific Presentations tab of the T